Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio— have products in the pipeline that could ...

Brain injuries are a leading cause of death and long-term disability in infants. Among the most common is neonatal ...

Mucopolysaccharidosis Type II (MPS II) also known as Hunter Syndrome is when the body lacks the enzyme to break down sugar molecules in the body and remove them.

What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...

If you ask people who the main characters are in Monster Hunter, they might say “the hunters” – but others will tell you: “It’s all about the monsters.” So many striking creatures have ...

January 16 - Hunter Sallis scored in bunches on his way to 30 points as Wake Forest overcame visiting Stanford for an 80-67 victory Wednesday night in Atlantic Coast Conference play at Winston ...

A collection of nearly 200 artworks by Hunter Biden was destroyed in the Los Angeles wildfires, The Post has confirmed. The art, valued at "millions of dollars," was kept in storage near the ...

Fifteen-year-old Dominic Henriquez from Prosper, Texas, is bringing hope to boys like him who live with Hunter syndrome, a rare genetic disorder that primarily affects males. Dominic’s journey ...

The identity of the deceased is currently unknown, police said. Two local duck hunters in North Carolina ended up discovering human remains during an outing earlier this week, police said.

“She was my rainbow baby that I got to have a beautiful 7 months with before I was notified that she was deceased,” she told jurors. The state also called longtime friends and fellow retired ...

Nip­pon Shinyaku has paid $110 mil­lion up­front for the rights to sell two of Re­genxbio’s gene ther­a­pies for mu­copolysac­cha­ri­do­sis in the US and Asia. … ...

RegenxBio said Tuesday that Kyoto, Japan’s Nippon Shinyaku Co. Ltd. will develop and commercialize its one-time gene therapies for Hunter syndrome and Hurler syndrome, both affecting children.